109 related articles for article (PubMed ID: 18578477)
1. Chemo-enzymatic synthesis of (2S,4R)-2-amino-4-(3-(2,2-diphenylethylamino)-3-oxopropyl)pentanedioic acid: a novel selective inhibitor of human excitatory amino acid transporter subtype 2.
Sagot E; Jensen AA; Pickering DS; Pu X; Umberti M; Stensbøl TB; Nielsen B; Assaf Z; Aboab B; Bolte J; Gefflaut T; Bunch L
J Med Chem; 2008 Jul; 51(14):4085-92. PubMed ID: 18578477
[TBL] [Abstract][Full Text] [Related]
2. The excitatory amino acid transporters: pharmacological insights on substrate and inhibitor specificity of the EAAT subtypes.
Bridges RJ; Esslinger CS
Pharmacol Ther; 2005 Sep; 107(3):271-85. PubMed ID: 16112332
[TBL] [Abstract][Full Text] [Related]
3. Binding and transport of [3H](2S,4R)- 4-methylglutamate, a new ligand for glutamate transporters, demonstrate labeling of EAAT1 in cultured murine astrocytes.
Apricò K; Beart PM; Crawford D; O'Shea RD
J Neurosci Res; 2004 Mar; 75(6):751-9. PubMed ID: 14994336
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological characterization of human excitatory amino acid transporters EAAT1, EAAT2 and EAAT3 in a fluorescence-based membrane potential assay.
Jensen AA; Bräuner-Osborne H
Biochem Pharmacol; 2004 Jun; 67(11):2115-27. PubMed ID: 15135308
[TBL] [Abstract][Full Text] [Related]
5. Comparison of [(3)H]-(2S,4R)-4-methylglutamate and [(3)H]D-aspartate as ligands for binding and autoradiographic analyses of glutamate transporters.
Apricò K; Beart PM; Crawford D; O'shea RD
Neurochem Int; 2007 Dec; 51(8):507-16. PubMed ID: 17590480
[TBL] [Abstract][Full Text] [Related]
6. Excitatory amino acid transporters as potential drug targets.
Bunch L; Erichsen MN; Jensen AA
Expert Opin Ther Targets; 2009 Jun; 13(6):719-31. PubMed ID: 19456273
[TBL] [Abstract][Full Text] [Related]
7. Chemo-enzymatic synthesis of a series of 2,4-syn-functionalized (S)-glutamate analogues: new insight into the structure-activity relation of ionotropic glutamate receptor subtypes 5, 6, and 7.
Sagot E; Pickering DS; Pu X; Umberti M; Stensbøl TB; Nielsen B; Chapelet M; Bolte J; Gefflaut T; Bunch L
J Med Chem; 2008 Jul; 51(14):4093-103. PubMed ID: 18578478
[TBL] [Abstract][Full Text] [Related]
8. Chemoenzymatic synthesis of a series of 4-substituted glutamate analogues and pharmacological characterization at human glutamate transporters subtypes 1-3.
Alaux S; Kusk M; Sagot E; Bolte J; Jensen AA; Bräuner-Osborne H; Gefflaut T; Bunch L
J Med Chem; 2005 Dec; 48(25):7980-92. PubMed ID: 16335922
[TBL] [Abstract][Full Text] [Related]
9. Glutamate-based therapeutic approaches: targeting the glutamate transport system.
Dunlop J
Curr Opin Pharmacol; 2006 Feb; 6(1):103-7. PubMed ID: 16368269
[TBL] [Abstract][Full Text] [Related]
10. Expression of excitatory amino acid transporter interacting protein transcripts in the thalamus in schizophrenia.
Huerta I; McCullumsmith RE; Haroutunian V; Giménez-Amaya JM; Meador-Woodruff JH
Synapse; 2006 Jun; 59(7):394-402. PubMed ID: 16485262
[TBL] [Abstract][Full Text] [Related]
11. 4,4-Dimethyl- and diastereomeric 4-hydroxy-4-methyl- (2S)-glutamate analogues display distinct pharmacological profiles at ionotropic glutamate receptors and excitatory amino acid transporters.
Bunch L; Pickering DS; Gefflaut T; Vinatier V; Helaine V; Amir A; Nielsen B; Jensen AA
ChemMedChem; 2009 Nov; 4(11):1925-9. PubMed ID: 19731281
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the tritium-labeled analog of L-threo-beta-benzyloxyaspartate binding to glutamate transporters.
Shimamoto K; Otsubo Y; Shigeri Y; Yasuda-Kamatani Y; Satoh M; Kaneko S; Nakagawa T
Mol Pharmacol; 2007 Jan; 71(1):294-302. PubMed ID: 17047096
[TBL] [Abstract][Full Text] [Related]
13. Inhibitors of glutamate transport modulate distinct patterns in brain metabolism.
Moussa CE; Rae C; Bubb WA; Griffin JL; Deters NA; Balcar VJ
J Neurosci Res; 2007 Feb; 85(2):342-50. PubMed ID: 17086545
[TBL] [Abstract][Full Text] [Related]
14. 4-Alkylated homoibotenic acid (HIBO) analogues: versatile pharmacological agents with diverse selectivity profiles towards metabotropic and ionotropic glutamate receptor subtypes.
Madsen U; Pickering DS; Nielsen B; Bräuner-Osborne H
Neuropharmacology; 2005; 49 Suppl 1():114-9. PubMed ID: 15996690
[TBL] [Abstract][Full Text] [Related]
15. Glutamate transporter blockers for elucidation of the function of excitatory neurotransmission systems.
Shimamoto K
Chem Rec; 2008; 8(3):182-99. PubMed ID: 18563834
[TBL] [Abstract][Full Text] [Related]
16. Structure-activity relationship study of selective excitatory amino acid transporter subtype 1 (EAAT1) inhibitor 2-amino-4-(4-methoxyphenyl)-7-(naphthalen-1-yl)-5-oxo-5,6,7,8-tetrahydro-4H-chromene-3-carbonitrile (UCPH-101) and absolute configurational assignment using infrared and vibrational circular dichroism spectroscopy in combination with ab initio Hartree-Fock calculations.
Huynh TH; Shim I; Bohr H; Abrahamsen B; Nielsen B; Jensen AA; Bunch L
J Med Chem; 2012 Jun; 55(11):5403-12. PubMed ID: 22594609
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and receptor assay of aromatic-ethynyl-aromatic derivatives with potent mGluR5 antagonist activity.
Alagille D; Baldwin RM; Roth BL; Wroblewski JT; Grajkowska E; Tamagnan GD
Bioorg Med Chem; 2005 Jan; 13(1):197-209. PubMed ID: 15582465
[TBL] [Abstract][Full Text] [Related]
18. Chemoenzymatic Synthesis and Pharmacological Characterization of Functionalized Aspartate Analogues As Novel Excitatory Amino Acid Transporter Inhibitors.
Fu H; Zhang J; Tepper PG; Bunch L; Jensen AA; Poelarends GJ
J Med Chem; 2018 Sep; 61(17):7741-7753. PubMed ID: 30011368
[TBL] [Abstract][Full Text] [Related]
19. Reactive astrocytes and activated microglial cells express EAAT1, but not EAAT2, reflecting a neuroprotective potential following ischaemia.
Beschorner R; Simon P; Schauer N; Mittelbronn M; Schluesener HJ; Trautmann K; Dietz K; Meyermann R
Histopathology; 2007 Jun; 50(7):897-910. PubMed ID: 17543080
[TBL] [Abstract][Full Text] [Related]
20. β-Sulfonamido Functionalized Aspartate Analogues as Excitatory Amino Acid Transporter Inhibitors: Distinct Subtype Selectivity Profiles Arising from Subtle Structural Differences.
Hansen JC; Bjørn-Yoshimoto WE; Bisballe N; Nielsen B; Jensen AA; Bunch L
J Med Chem; 2016 Oct; 59(19):8771-8786. PubMed ID: 27636002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
